DOI: https://dx.doi.org/10.18565/pharmateca.2023.14.40-43
Успенский Ю.П., Гулунов З.Х.
1) Санкт-Петербургский государственный педиатрический медицинский университет, Санкт-Петербург, Россия; 2) Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова, Санкт-Петербург, Россия
1. Петров С.В., Успенский Ю.П., Фоминых Ю.А. Клинический случай осложненного течения болезни крона: трудности диагностики и лечения. Univer Ther J. 2022;4(3):39–46. 2. Успенский Ю.П., Иванов С.В., Фоминых Ю.А. Особенности осложненного течения и внекишечных проявлений воспалительных заболеваний кишечника. Univer Ther J. 2023;5(2):68–83. 3. Diaz L., Hernandez-Oquet R.E., Deshpande A.R., et al. Upper gastrointestinal involvement in crohn disease: histopathologic and endoscopic findings. South Med J. 2015;108:695–700. 4. Greuter T., Piller A., Fournier N., et al. M.; Swiss IBD Cohort Study Group. Upper Gastrointestinal Tract Involvement in Crohn’s Disease: Frequency, Risk Factors, and Disease Course. J Crohns Colit. 2018;12(12):1399–409. Doi: 10.1093/ecco-jcc/jjy121. 5. De Felice K.M., Katzka D.A., Raffals L.E. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106–13. 6. Witte A.M., Veenendaal R.A., Van Hogezand R.A., et al. Crohn’s disease of the upper gastrointestinal tract: the value of endoscopic examination. Scand J Gastroenterol. Suppl. 1998;225:100–5. 7. Naranjo-Rodriguez A., Solorzano-Peck G., Lopez-Rubio F., et al. Isolated oesophageal involvement of Crohn’s disease. Eur J Gastroenterol Hepatol. 2003;15:1123–26. 8. Loreto-Brand M., Fernfndez-Perez A., Celeiro-Munoz C., et al. Crohn’s disease: upper gastrointestinal involvement. Rev Gastroenterol Mex. 2015;80:282–85. 9. Ramaswamy K., Jacobson K., Jevon G., et al. Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr. 2003;36:454–58. 10. Mintz M.J., Ananthakrishnan A.N. Phenotype and natural history of inflammatory bowel disease in patients with concomitant eosinophilic esophagitis. Inflamm Bowel Dis. 2021;27:469–75. 11. Decker G.A., Loftus E.V., Pasha T.M., et al. Crohn’s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7:113–19. 12. Ammoury R.F., Pfefferkorn M.D. Significance of esophageal Crohn disease in children. J Pediatr Gastroenterol Nutr. 2011;52:291–4. 13. Rudolph I., Goldstein F., DiMarino A.J. Crohn’s disease of the esophagus: three cases and a literature review. Can J Gastroenterol. 2001;15:117–22. 14. Pimentel A.M., Rocha R., Santana G.O. Crohn’s disease of esophagus, stomach and duodenum. World J Gastrointest Pharmacol Ther. 2019;10:35–49. 15. Horjus Talabur Horje C.S., Meijer J., Rovers L., et al. Prevalence of upper gastrointestinal lesions at primary diagnosis in adults with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:1896–901. 16. Fujiya M., Sakatani A., Dokoshi T., et al. A bamboo joint-like appearance is a characteristic finding in the upper gastrointestinal tract of Crohn’s disease patients: a case-control study. Medicine (Baltimore). 2015;94:e1500. 17. Greenstein A.J., Present D.H., Sachar D.B., et al. Gastric fistulas in Crohn’s disease. Report of cases. Dis Colon Rectum. 1989;32:888–92. 18. Genta R.M., Sonnenberg A. Non-Helicobacter pylori gastritis is common among paediatric patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012;35:1310–16. 19. McHugh J.B., Gopal P., Greenson J.K. The clinical significance of focally enhanced gastritis in children. Am J Surg Pathol. 2013;37:295–99. 20. Oberhuber G., Puspok A., Oesterreicher C., et al. Focally enhanced gastritis: a frequent type of gastritis in patients with Crohn’s disease. Gastroenterol. 1997;112:698–706. 21. Hirokawa M., Shimizu M., Terayama K., et al. Bamboo-jointlike appearance of the stomach: a histopathological study. APMIS. 1999;107:951–6. 22. Isaacs K.L. Upper gastrointestinal tract endoscopy in inflammatory bowel disease. Gastrointest Endosc Clin N Am. 2002; 12:451–62. 23. Nugent F.W., Roy M.A. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989;84:249–54. 24. Sakuraba A., Iwao Y., Matsuoka K., et al. Endoscopic and pathologic changes of the upper gastrointestinal tract in Crohn’s disease. Biomed Res Int. 2014;2014:610767. 25. Tobin J.M., Sinha B., Ramani P., et al. Upper gastrointestinal mucosal disease in pediatric Crohn disease and ulcerative colitis: a blinded, controlled study. J Pediatr Gastroenterol Nutr. 2001;32:443–48. 26. Patterson E.R., Shmidt E., Oxentenko A.S., et al. Normal villous architecture with increased intraepithelial lymphocytes: a duodenal manifestation of Crohn disease. Am J Clin Pathol. 2015;143:445–50. 27. Ивашкин В.Т., Шелыгин Ю.А., Абдулганиева Д.И. Клинические рекомендации диагностике и лечению болезни Крона у взрослых (проект). Колопроктология. 2020;19(2):8–38. Ivashkin V.T., Shelygin Yu.A., Abdulganieva D.I. Clinical recommendations for the diagnosis and treatment of Crohn’s disease in adults (draft). Koloproktologiya. 2020;19(2):8–38. (In Russ.)]. 28. Щукина О.Б., Иванов С.В., Шотик А.В. Практические рекомендации для терапевтов по диагностике и лечению болезни крона. Univer Ther J. 2021;3(1):71–85. Shchukina O.B.,Ivanov S.V., Shotik A.V.
Автор для связи: Заурбек Хазбиевич Гулунов, ассистент кафедры факультетской терапии им. проф. В.А. Вальдмана, Санкт-Петербургский государственный педиатрический медицинский университет, Санкт-Петербург, Россия; zaurito@list.ru ORCID / eLibrary SPIN:
Ю.П. Успенский (Y.P. Uspensky), https://orcid.com/0000-0001-6434-1267; eLibrary SPIN: 7306-1228
З.Х. Гулунов (Z.Kh. Gulunov), http://orcid.com/0000-0002-1866-9736; eLibrary SPIN: 2945-4370